Table 1 Percent cells in each generation, based on CFSE staining, for the rapamycin treated samples shown in Figure 4B.
Generation | CD3/CD28/IL2+10 ng/ml rapamycin | CD3/CD28/IL2+100 ng/ml rapamycin | ||
|---|---|---|---|---|
| Â | FOXP3- (%) | FOXP3+ (%) | FOXP3- (%) | FOXP3+ (%) |
0 | 7.9 | 3.9 | 22.1 | 23.8 |
1 | 9.7 | 5.4 | 17 | 8.3 |
2 | 17.5 | 8.4 | 28.1 | 17 |
3 | 28.9 | 14.6 | 26.1 | 28.9 |
4 | 25.6 | 25.4 | 6.7 | 19.2 |
5 | 10.4 | 28.4 | - - - | 2.8 |
6 | - - - | 13.9 | - - - | - - - |
Total | 100 | 100 | 100 | 100 |